-
公开(公告)号:US20210030668A1
公开(公告)日:2021-02-04
申请号:US16964351
申请日:2019-01-28
发明人: Christoph SCHMITZ , Michael LINN
IPC分类号: A61K9/00
摘要: Described are: a multi-layer oral thin film, comprising at least two layers arranged one on top of the other, which each comprise at least one water-soluble polymer, these at least two layers being connected to one another by at least one sealing, characterised in that the at least one sealing is not provided over the entire surface; a method for producing same; and use thereof as a medicament.
-
公开(公告)号:US10898449B2
公开(公告)日:2021-01-26
申请号:US16788128
申请日:2020-02-11
发明人: Patrick Mohr , René Rietscher , René Eifler , Olga Bourquain
IPC分类号: A61K9/70 , A61P25/28 , A61P25/18 , A61P25/24 , A61P25/00 , A61P25/16 , A61K31/407 , A61P9/12 , A61K9/00
摘要: The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of asenapine comprising a self-adhesive layer structure containing a therapeutically effective amount of asenapine, such asenapine TTS for use in a method of treatment, processes of manufacture of such TTS as well as asenapine and transdermal therapeutic systems containing asenapine for use in a method of treatment and to a method of treating a human patient by transdermal administration of asenapine.
-
公开(公告)号:US20210000756A1
公开(公告)日:2021-01-07
申请号:US16979575
申请日:2019-03-11
发明人: Marco EMGENBROICH , Gabriel WAUER , Michael LINN , Rolf BÖHM , Christoph SCHMITZ , Regine KAUFMANN , Hans-Werner WOLF , Nico REUM , Anna SCHLÜTER
IPC分类号: A61K9/70 , A61K31/485 , A61K31/465 , A61K31/27 , A61K47/32 , B29D7/01
摘要: The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of an active agent comprising an active agent-containing layer structure, said active agent-containing layer structure comprising A) a backing layer, B) an active agent-containing layer, wherein the active agent-containing layer comprises a therapeutically effective amount of the active agent and at least one silicone acrylic hybrid polymer, and C) a skin contact layer, wherein the skin contact layer comprises at least one silicone acrylic hybrid polymer.
-
公开(公告)号:US20210000755A1
公开(公告)日:2021-01-07
申请号:US16979572
申请日:2019-03-11
发明人: Marco EMGENBROICH , Gabriel WAUER
IPC分类号: A61K9/70 , A61K31/485 , A61K47/12 , A61K47/32
摘要: The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of buprenorphine comprising at least one silicone acrylic hybrid polymer.
-
公开(公告)号:US10772845B2
公开(公告)日:2020-09-15
申请号:US13512403
申请日:2010-12-02
IPC分类号: A61K38/09 , A61K9/70 , A61K38/095
摘要: The invention relates to a transdermal therapeutic system (TTS) which is suited for the administration of a peptide to a patient through skin treated with ablation. The transdermal therapeutic system incorporates a back layer and an active substance-containing layer that includes at least one peptide and a carrier substance.
-
公开(公告)号:US10653636B2
公开(公告)日:2020-05-19
申请号:US10553708
申请日:2004-04-08
申请人: Stefan Bracht
发明人: Stefan Bracht
IPC分类号: A61K9/70
摘要: A medical active substance patch comprising a matrix of monolayer or multilayer configuration with at least one active substance-containing layer and comprising a backing layer connected with the matrix. The active substance patch is transparent or at least translucent, and in the state of having been applied to the skin of a first person, the patch has a lightness colour value L1 at a place of the skin covered by the patch which is not less than 50% and not more than 200% of a lightness colour value L2, L2 being the lightness value of the region of the skin of the same person which surrounds the applied patch. The same is true of the skin of a second or any other person, provided that for all the persons mentioned L2 is in the range from 5° to 100°, namely from 20° to 90°.
-
公开(公告)号:US20200071571A1
公开(公告)日:2020-03-05
申请号:US16318430
申请日:2017-07-19
发明人: Marco EMGENBROICH
IPC分类号: C09J7/38 , C08G77/442 , C08G77/20 , C09J183/10 , C09J11/06 , C09J183/04 , C08G77/06 , C08G77/382 , A61K9/70
摘要: A method of inverting the phase arrangement of the silicone phase and the acrylic phase in a silicone acrylic hybrid composition, the silicone acrylic hybrid composition comprising: a) a silicone acrylic hybrid pressure sensitive adhesive, and b) a solvent, wherein the phase arrangement of the silicone phase and the acrylic phase in the initial silicone acrylic hybrid composition forming a continuous external phase and a discontinuous internal phase is determined by the solvent, comprising the step of adding an activator to the silicone acrylic hybrid composition, wherein the activator a) is liquid at 20° C. and 1013 mbar, b) has a boiling point which is higher than the boiling point of the solvent and/or has a vapor pressure at 20° C. which is lower than the vapor pressure of the solvent contained in the silicone acrylic hybrid composition, and c) provides better dissolution properties for the inner phase of the initial silicone acrylic hybrid composition than the solvent contained in the silicone acrylic hybrid composition.
-
公开(公告)号:US20190192506A1
公开(公告)日:2019-06-27
申请号:US16288911
申请日:2019-02-28
发明人: Thomas Hille , Michael Horstmann , Walter Mueller
IPC分类号: A61K31/485 , A61K9/70 , A61M37/00 , A61K47/12
CPC分类号: A61K31/485 , A61K9/7053 , A61K9/7069 , A61K9/7084 , A61K9/7092 , A61K47/12 , A61M37/00
摘要: The invention relates to a transdermal therapeutic system for administering the active substance buprenorphine. Said system comprises at least one carboxylic acid that determines the solubility of buprenorphine in the matrix layer and that can likewise be absorbed. The transdermal therapeutic system according to the invention is used in the treatment of pain and characterized by a considerably increased utilization of the active substance.
-
29.
公开(公告)号:US10130589B2
公开(公告)日:2018-11-20
申请号:US15884587
申请日:2018-01-31
申请人: UCB Pharma GmbH
发明人: Hans-Michael Wolff , Christoph Arth , Luc Quere , Walter Müller
IPC分类号: A61K31/381 , A61K9/70
摘要: The present invention relates to a method for stabilizing rotigotine, the method comprising providing a solid dispersion comprising polyvinylpyrrolidone and a non-crystalline form of rotigotine, wherein the weight ratio of rotigotine to polyvinylpyrrolidone is in a range from about 9:3.5 to about 9:6. The present invention also relates to a solid dispersion comprising a dispersing agent and a dispersed phase, said dispersed phase comprising rotigotine and polyvinylpyrrolidone, wherein the weight ratio of rotigotine to polyvinylpyrrolidone is in a range from about 9:3.5 to about 9:6, a pharmaceutical composition comprising such a solid dispersion, in particular a transdermal therapeutic system, as well as a method for the preparation thereof.
-
公开(公告)号:US10105526B2
公开(公告)日:2018-10-23
申请号:US15231097
申请日:2016-08-08
发明人: Sebastian Scherr , Karsten Heuser
摘要: A microneedle system and method for production thereof. From a board a web grating is produced which has a plurality of grating nodes each defined by three apertures and which has web grating wedges. The microneedle system comprising a board and a plurality of openings delimited circumferentially by a web grating, having at each opening at least one web grating wedge having a needle-shaped tip which projects from the board and which is oriented at least approximately normal to the board. Web grating wedges having needle-shaped tips protrude into each aperture from at least three different directions. In order to produce openings, at least all the web grating wedges which protrude into an aperture are bent by a punch and the needle-shaped tips thereof are oriented normal to the plane of the web grating. At least two web grating wedges are arranged at each opening.
-
-
-
-
-
-
-
-
-